LWPES/PAS
Program
Schedule
(as of
December 31, 2001) |
Times
Yet To Be Determined:
Thursday,
May 2, 2002
12:00pm –
5:00pm
LWPES Executive
Board Meeting
Friday,
May 3, 2002
8:00am –
12:00pm
LWPES Corporate
Advisory Board
12:00pm
– 2:30pm
LWPES
Drug & Therapeutic Committee
LWPES
Intersex Committee
LWPES
Corporate Advisory Board
1:00pm –
5:00pm
LWPES Executive
Board Meeting
6:00pm
– 8:00pm
LWPES Reception
Saturday,
May 4, 2002
7:00am –
8:30am
LWPES Past
Presidents' Breakfast
8:30am –
10:45am
LWPES Plenary
Session I
8:30am
–8:45am
Opening
Remarks and Awards
8:45am
–9:45am
Genentech Clinical Scholar
The
Role of IGFBP3 in Mediating p53-Induced Cell Apoptosis
(tentative)
Adda Grimberg, MD, Pediatric Endocrinology and
Diabetes, The Children's Hospital of Philadelphia
9:45am
–10:45am
Lawson Wilkins Lecture
Endocrine
Effects of Childhood Cancer
Stephen Shalet, MD, Department of Endocrinology,
Christie Hospital, Manchester, UK
10:45am
– 11:00am
Break
11:00am
– 12:00pm
LWPES Business
Meeting (members only)
12:00pm
– 1:00pm
Lunch Break
1:00pm
– 3:00pm
LWPES
Esoterix Lecture/Genetics Symposium
Genetic
Testing in Endocrinology: Ethical Considerations
Norman Fost, MD, University of Wisconsin, Madison, WI
Overview of Human Genetics/Genomics: Relevance to
Pediatric Endocrinology
Barton Childs, MD, Johns Hopkins Medical Institutions,
Baltimore, MD
Single Gene Defects and What They Have Taught Us About
Developmental and Clinical Endocrinology
Keith Parker, MD, PhD, University of Texas Southwestern
Medical School, Dallas, TX
3:00pm
– 3:15pm
Break
3:15pm
– 5:15pm
Endocrinology
Platform Session I
PAS/LWPES
Original Science Abstracts
(Abstract session
information will be posted in mid-February)
4:00pm
– 7:30pm
PAS/LWPES
Exhibits Open
5:15pm
– 7:15pm
Poster
Session I, PAS Opening Reception & Exhibits
Endocrinology
Posters I
(Exhibits
open at 4:00 pm)
(Abstract session
information will be posted in mid-February)
Sunday, May 5,
2002
7:00am –
8:00am
LWPES Program
Directors' Breakfast
8:00am
– 10:00am
LWPES
Plenary Session II
8:00am
–9:00am
Presidential Lecture
Barbara
Lippe, MD, Pharmacia, Inc., Los Angeles, CA
9:00am
–10:00am
Robert
Blizzard Lecture
Nelly
Mauras, MD, Nemours Children's Clinic, Jacksonville, FL
10:00am
– 10:15am
Break
10:00am
– 3:00pm
PAS/LWPES
Exhibits Open
10:15am
– 11:45am
LWPES Professional and Clinical Affairs Program:
Reimbursement Issues in Diabetes Care
Organizers:
Georgeanna Klingensmith, MD, Barbara Davis Center for
Childhood Diabetes, Denver, CO; Jay Cohen, MD, The
Endocrine Clinic, PC, Memphis, TN
Cost
and Reimbursement Data for Diabetes Clinic Services
Gail Richards, MD, Children’s Hospital and Regional
Medical Center, Seattle, WA
Logistics of Contracting, and
Outcomes — Both Financial and Medical
William
Tamborlane, MD, Yale University, New Haven, CT
Karen Rubin, MD, University of Connecticut, Farmington, CT
Setting Up Outpatient Diabetes
Education Programs
Denis
Danneman, MD, Hospital for Sick Children, Toronto, Canada
11:45am
– 1:45pm
Poster
Session II
& Exhibits
Endocrinology Posters II
(Abstract session
information will be posted in mid-February)
1:45pm
– 2:30pm
Career
Development
LWPES
Fellows and Junior Faculty Session
2:30pm
– 4:00pm
PAS/LWPES
Joint State of the Art:
Insulin Resistance Syndromes
Chairs: Alan Rogol, Insmed
Pharmaceuticals, Inc., Glen Allen, VA & Charlotte
Boney, Rhode Island Hospital, Providence, RI
Insulin resistance is
the underlying factor in many of the consequences of
obesity in childhood and adolescence, including ovarian
hyperandrogenism, hypertension, hyperlipidemia, and Type 2
diabetes. Obesity, dyslipidemia, and Type 2 diabetes are
components of SyndromeX in adults, a serious public health
issue. In addition, insulin has a role in the regulation
of leptin, the major signal of adiposity to the brain. Dr.
Arslanian will discuss insulin resistance in polycystic
ovary disease and Type 2 diabetes. Dr. Freedman will
review the cardiac risk factors related to insulin
resistance, and Dr. Roemmich will discuss the insulin-leptin
axis in obesity and puberty.
Insulin Resistance:
It's Not for Adults Only
Silva A. Arslanian, University of Pittsburgh, Children’s
Hospital of Pittsburgh, Pittsburgh, PA
Clustering of Coronary Heart Disease Risk Factors in
Obese Children
David Freedman, Centers for Disease Control, Atlanta,
GA
The Insulin–Leptin Axis in Puberty
James Roemmich, University of Buffalo, Buffalo, NY
Sponsored jointly with the Lawson
Wilkins Pediatric Endocrine Society, the American Academy
of Pediatrics and the Pediatric Academic Societies
4:00pm
– 4:15pm
Break
4:15pm
– 5:45pm
Endocrinology
Platform Session II
PAS/LWPES
Original Science Abstracts
(Abstract session
information will be posted in mid-February)
Monday, May 6,
2002
8:00am
– 10:00am
Endocrinology
Platform Session III
PAS/LWPES
Original Science Abstracts
(Abstract session
information will be posted in mid-February)
10:00am
– 10:30am
Break
10:30am
– 12:30pm
LWPES
Plenary Session III – Mini Symposium:
Breaking the Obesity–Type 2 Diabetes Link
Opening
Remarks
Desmond Schatz, MD, Chair of the LWPES Diabetes
Committee, University of Florida, Gainesville, FL
Metformin Therapy in Obesity
Michael Freemark, MD, Duke University Medical Center,
Durham, NC
Macronutrient Management in Obesity
David Ludwig, MD, Children’s Hospital, Boston, MA
New Advances: Adiponectin in Diabetes and Obesity
Harvey Lodish, PhD, Whitehead Institute, Boston, MA
11:30am
– 2:30pm
PAS/LWPES
Exhibits Open
4:00pm
– 6:45pm
PAS/LWPES
Exhibits Open
|
